Surgery Partners Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
J. Evans
Chief executive officer
US$6.5m
Total compensation
| CEO salary percentage | 16.3% |
| CEO tenure | 5yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues Pushing Shares 28% Lower
Dec 08
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Nov 11Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues
Oct 24Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger
Oct 05Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward
Jul 25Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden
Jul 13Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement
Jun 21We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now
May 31Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion
Apr 24Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Mar 18Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Feb 27The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)
Dec 19Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)
Oct 26Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?
Sep 17Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?
Aug 26The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising
Jul 21Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit
Jun 15A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
May 26There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital
Apr 14Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet
Mar 24Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jan 24We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt
Sep 26The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence
Aug 15Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M
Aug 02Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders
Jul 02Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Jun 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$61m |
| Jun 30 2024 | n/a | n/a | -US$34m |
| Mar 31 2024 | n/a | n/a | US$600k |
| Dec 31 2023 | US$6m | US$1m | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$54m |
| Mar 31 2023 | n/a | n/a | -US$92m |
| Dec 31 2022 | US$6m | US$1m | -US$55m |
| Sep 30 2022 | n/a | n/a | -US$31m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | n/a | n/a | -US$38m |
| Dec 31 2021 | US$4m | US$1m | -US$81m |
| Sep 30 2021 | n/a | n/a | -US$86m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$150m |
| Dec 31 2020 | US$4m | US$916k | -US$156m |
| Sep 30 2020 | n/a | n/a | -US$179m |
| Jun 30 2020 | n/a | n/a | -US$132m |
| Mar 31 2020 | n/a | n/a | -US$119m |
| Dec 31 2019 | US$5m | US$435k | -US$110m |
Compensation vs Market: J.'s total compensation ($USD6.46M) is about average for companies of similar size in the US market ($USD6.66M).
Compensation vs Earnings: J.'s compensation has increased whilst the company is unprofitable.
CEO
J. Evans (47 yo)
5yrs
Tenure
US$6,457,600
Compensation
Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7yrs | US$250.00k | 0.080% $ 2.1m | |
| CEO & Director | 5yrs | US$6.46m | 0.38% $ 10.1m | |
| Executive VP & CFO | 2.9yrs | US$3.52m | 0.076% $ 2.0m | |
| Executive VP and Chief Administrative & Development Officer | 4.9yrs | US$3.09m | 0.15% $ 3.9m | |
| Executive VP & Chief Strategy Officer | 3yrs | US$1.68m | 0.031% $ 844.4k | |
| Senior Vice President of Operations - Central Region | less than a year | no data | no data | |
| Senior Vice President of Corporate Finance & Controller | 2.7yrs | no data | no data | |
| Senior VP & Chief Information Officer | 3.5yrs | no data | no data | |
| Senior VP & Chief Compliance Officer | 6.2yrs | no data | no data | |
| General Counsel & Senior VP | less than a year | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.9yrs | no data | 0.024% $ 644.5k | |
| Chief Growth Officer | 5.4yrs | US$1.30m | 0.081% $ 2.2m |
3.0yrs
Average Tenure
50yo
Average Age
Experienced Management: SGRY's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7yrs | US$250.00k | 0.080% $ 2.1m | |
| CEO & Director | 5yrs | US$6.46m | 0.38% $ 10.1m | |
| Director | 7.3yrs | US$260.00k | 0.040% $ 1.1m | |
| Director | 3.7yrs | no data | no data | |
| Independent Director | 9.1yrs | US$285.00k | 0.054% $ 1.4m | |
| Independent Director | 3.9yrs | US$260.00k | 0.014% $ 376.2k | |
| Independent Director | 8.3yrs | US$280.00k | 0.046% $ 1.2m | |
| Independent Director | 5.7yrs | US$260.00k | 0.022% $ 581.4k | |
| Director | 7.4yrs | no data | no data | |
| Director | 6.4yrs | no data | no data |
6.7yrs
Average Tenure
58yo
Average Age
Experienced Board: SGRY's board of directors are considered experienced (6.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 23:21 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Surgery Partners, Inc. is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Sarah James | Barclays |
| Andrew Mok | Barclays |